KWM
BIIB icon

Keebeck Wealth Management’s Biogen BIIB Stock Holding History

Keebeck Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Buy
+1,395
New +$267K 0.03% 378
2020
Q3 		– Sell
-1,512
Closed -$404K – 197
2020
Q2 		$404K Hold
1,512
– – 0.13% 123
2020
Q1 		$478K Buy
+1,512
New +$459K 0.2% 96

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Keebeck Wealth Management's BIIB Position: Q2 2026 in Review

Keebeck Wealth Management opened a new position in Biogen (BIIB) in Q2 2026: 1,395 shares worth $301K. The stake represents 0.03% of the portfolio and ranks #378 among its holdings. This is a return to the name: Keebeck Wealth Management previously reported a position in BIIB as recently as Q2 2020.

Keebeck Wealth Management first reported a position in BIIB in Q1 2020 and has held it in 3 quarters since. The position peaked at $478K in Q1 2020. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Keebeck Wealth Management held 1,395 shares of Biogen worth $301K as of Q2 2026.
  • Biogen was a new Keebeck Wealth Management position in Q2 2026.
  • Biogen made up 0.03% of Keebeck Wealth Management's portfolio in Q2 2026, its #378 holding.
  • Keebeck Wealth Management first reported a position in Biogen in Q1 2020 and has held it in 3 quarters since.
  • Keebeck Wealth Management's Biogen position peaked at $478K in Q1 2020.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Keebeck Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.